AI-generated analysis. Always verify with the original filing.
Xenon Pharmaceuticals Inc. entered into an Underwriting Agreement on March 10, 2026. The Company filed an 8-K on March 12, 2026, including the Underwriting Agreement as Exhibit 1.1.
Event Type
Disclosure
Mandatory
Variant
8-K
. Item 8.01 Other Events On March 10, 2026, Xenon Pharmaceuticals Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) wit
Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description 1.1 Underwriting Agreement, dated March 10, 2026, among Xenon Pharmaceuticals Inc., J
Material Agreement